tyrphostin ag 1024 has been researched along with Lung Neoplasms in 6 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JH | 1 |
| Choi, SI | 1 |
| Kim, RK | 1 |
| Cho, EW | 1 |
| Kim, IG | 1 |
| Wei, YH | 1 |
| Tang, HX | 1 |
| Liao, YD | 1 |
| Fu, SL | 1 |
| Xu, LQ | 1 |
| Chen, G | 1 |
| Zhang, C | 1 |
| Ju, S | 1 |
| Liu, ZG | 1 |
| You, LK | 1 |
| Yu, L | 1 |
| Zhou, S | 1 |
| Zovko, A | 1 |
| Novak, M | 1 |
| Hååg, P | 1 |
| Kovalerchick, D | 1 |
| Holmlund, T | 1 |
| Färnegårdh, K | 1 |
| Ilan, M | 1 |
| Carmeli, S | 1 |
| Lewensohn, R | 2 |
| Viktorsson, K | 1 |
| Hurbin, A | 2 |
| Dubrez, L | 2 |
| Coll, JL | 2 |
| Favrot, MC | 2 |
| Cosaceanu, D | 1 |
| Carapancea, M | 1 |
| Alexandru, O | 1 |
| Budiu, R | 1 |
| Martinsson, HS | 1 |
| Starborg, M | 1 |
| Vrabete, M | 1 |
| Kanter, L | 1 |
| Dricu, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1 Study in Humans Evaluating the Safety of Rectus Sheath Implantation of Diffusion Chambers Encapsulating Autologous Malignant Glioma Cells Treated With Insulin-Like Growth Factor Receptor-1 Antisense Oligodeoxynucleotide in 12 Patients With Recurre[NCT01550523] | Phase 1 | 13 participants (Actual) | Interventional | 2012-02-09 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 other studies available for tyrphostin ag 1024 and Lung Neoplasms
| Article | Year |
|---|---|
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1.
Topics: A549 Cells; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Calcium-Binding Protei | 2018 |
Effects of insulin-like growth factor 1 receptor and its inhibitor AG1024 on the progress of lung cancer.
Topics: Adult; Aged; Animals; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Disease Models, Animal; Di | 2015 |
Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Erb | 2016 |
Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.
Topics: Amphiregulin; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Culture Media, Condi | 2002 |
Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.
Topics: Amphiregulin; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Culture Media, Serum-Free | 2003 |
Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
Topics: Antibodies; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Humans; Lung | 2007 |